• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
Abstract Recent reports estimate that 0.6% of adults in the United States, or approximately 1.4 million persons, identify as transgender. Despite gains in rights and media attention, the reality is that transgender persons experience health disparities, and a dearth of research and evidence-based guidelines remains regarding their specific health needs. The lack of research to characterize cardiovascular disease (CVD) and CVD risk factors in transgender populations receiving cross-sex hormone therapy (CSHT) limits appropriate primary and specialty care. As with hormone therapy in cisgender persons (that is, those ...
Source: Annals of Internal Medicine - July 25, 2017 Category: Internal Medicine Authors: Streed CG, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M Tags: Ann Intern Med Source Type: research